A light-gated “membrane-to-mitochondria” sequentially targeted AIE photosensitizer for potentiated photodynamic therapy and imaging of breast cancer
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Tonghui Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Mitochondria, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Jiangsu Province Natural Science Foundation.
Abstract (Originalsprache)
Precision photodynamic therapy (PDT) requires efficient and selective subcellular organelle targeting to maximize antitumor efficacy while minimizing systemic toxicity. Herein, we developed a cationic photosensitizer, TBP-EQ, bearing a terminal quaternary ammonium group for light-triggered "plasma membrane-to-mitochondria" targeting. Unlike its mitochondrial-localized analogue TBP-E, TBP-EQ preferentially anchors on the cancer cell plasma membrane through enhanced electrostatic interactions. Upon light irradiation, TBP-EQ generates reactive oxygen species (ROS) in situ at the plasma membrane, inducing oxidative membrane damage and increasing membrane permeability, which in turn promotes its intracellular translocation and subsequent mitochondrial enrichment. This light-controlled sequential targeting strategy enables combined damage to both the plasma membrane and mitochondria, thereby amplifying photodynamic antitumor efficacy. In vivo investigations using a murine tumor model demonstrated that TBP-EQ exhibited prolonged tumor retention and achieved a high tumor inhibition rate of 97.5%, together with an excellent systemic safety profile. This work proposes a spatiotemporally regulated subcellular targeting strategy, providing a feasible approach for the development of high-performance precision photosensitizers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
- School of Medical Imaging, Xuzhou Medical University, Xuzhou 221004, China.
- Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China. Electronic address: xuzhoululi@163.com.
- Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China; School of Medical Imaging, Xuzhou Medical University, Xuzhou 221004, China. Electronic address: hancp@xzhmu.edu.cn.
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- Jiangsu Province Natural Science Foundation
Zitieren
APA
Huang, T., Huang, F., Shi, N., Wang, X., Ning, H., Lu, L., & Han, C. (2026). A light-gated “membrane-to-mitochondria” sequentially targeted AIE photosensitizer for potentiated photodynamic therapy and imaging of breast cancer. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110449
Vancouver
Huang T, Huang F, Shi N, Wang X, Ning H, Lu L, et al. A light-gated “membrane-to-mitochondria” sequentially targeted AIE photosensitizer for potentiated photodynamic therapy and imaging of breast cancer. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110449
BibTeX
@article{Huang2026,
author = {Huang, Tonghui and Huang, Fangzhu and Shi, Nian and Wang, Xing and Ning, Hangying and Lu, Li and Han, Cuiping},
title = {A light-gated “membrane-to-mitochondria” sequentially targeted AIE photosensitizer for potentiated photodynamic therapy and imaging of breast cancer},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110449}
}
EUVIMED